Evaluation of the efficacy and safety of Ganoderma lucidum mycelium-fermented liquid on gut microbiota and its impact on cardiovascular risk factors in human
Authors:
Open Access
- 21 September 2017
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (71) , 45093-45100
Abstract
Ganoderma lucidum is a Chinese traditional medicine with various bioactivities. However, the impacts of a Ganoderma lucidum mycelium-fermented liquid (GLFL), as a promising alternative product, on the gut microbes and cardiovascular risk factors have not been explored in humans to date. In this study, the composition of polysaccharides in GLFL was analyzed, and eight volunteers were fed with GLFL to investigate its influence on gut microbes and cardiovascular risk factors. High-throughput 16S rRNA gene sequencing technique was utilized to investigate the effects of GLFL on the diversity of the bacterial communities and the composition of gut microbiota. The results demonstrated that GLFL significantly altered β diversity and several phyla of gut microbiota in volunteers. Moreover, GLFL provided protection to humans by promoting the growth of probiotics, incorporating genus Lactobacillus (p < 0.05), and reducing pathogens containing genus Campylobacter and Aggregatibacter (p < 0.05); however, GLFL also had detrimental effects as it increased the population of Firmicutes/Bacteroidetes and opportunistic pathogens including genus Acinetobacter, Pseudomonas, Serratia, Stenotrophomonas, Peptococcus and S24-7 (p < 0.05) and reduced that of probiotics genus Lactococcus. Finally, we found that GLFL reduced plasma low-density lipoprotein cholesterol (LDL-c) in volunteers. This is helpful for further understanding the effect of Ganoderma lucidum or its related products on human body.Keywords
Funding Information
- National Natural Science Foundation of China (31270983)
This publication has 31 references indexed in Scilit:
- Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in miceInternational Journal of Biological Macromolecules, 2016
- Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiotaNature Communications, 2015
- Submerged cultivation of Ganoderma lucidum and the effects of its polysaccharides on the production of human cytokines TNF-α, IL-12, IFN-γ, IL-2, IL-4, IL-10 and IL-17New Biotechnology, 2015
- UPARSE: highly accurate OTU sequences from microbial amplicon readsNature Methods, 2013
- Antioxidant activities of five polysaccharides from Inonotus obliquusInternational Journal of Biological Macromolecules, 2012
- The Impact of the Gut Microbiota on Human Health: An Integrative ViewCell, 2012
- Ganoderma lucidum: A Potent Pharmacological MacrofungusCurrent Pharmaceutical Biotechnology, 2009
- Chromatographic and electrophoretic methods for Lingzhi pharmacologically active componentsJournal of Chromatography B, 2004
- Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharidesJournal of Biotechnology, 2003
- Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acidEnzyme and Microbial Technology, 2002